Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
5.90
+0.03 (0.51%)
Sep 11, 2026, 4:08 PM HKT
HKG:3613 Revenue
Beijing Tong Ren Tang Chinese Medicine Company had revenue of 601.89M HKD in the half year ending June 30, 2026, a decrease of -9.43%. This brings the company's revenue in the last twelve months to 1.35B, down -20.79% year-over-year. In the year 2025, Beijing Tong Ren Tang Chinese Medicine Company had annual revenue of 1.51B, down -6.10%.
Revenue (ttm)
1.35B
Revenue Growth
-20.79%
P/S Ratio
3.63
Revenue / Employee
1.77M
Employees
763
Market Cap
4.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.51B | -98.29M | -6.10% |
| Dec 31, 2024 | 1.61B | 86.70M | 5.69% |
| Dec 31, 2023 | 1.52B | -206.15M | -11.91% |
| Dec 31, 2022 | 1.73B | 174.94M | 11.24% |
| Dec 31, 2021 | 1.56B | 240.81M | 18.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsBeijing Tong Ren Tang Chinese Medicine Company News
- 14 days ago - Beijing Tong Ren Tang Chinese Medicine Company Earnings release: H1 2026 - Filings
- 5 months ago - Beijing Tong Ren Tang Chinese Medicine Company Earnings release: H2 2025 - Filings
- 5 months ago - Beijing Tong Ren Tang Chinese Medicine Company Annual report: H2 2025 - Filings